Re-examining the exclusion criterion of early recurrent ischemic stroke in intravenous thrombolysis: A meta-analysis
Current guidelines preclude the administration of intravenous tissue plasminogen activator in patients with early recurrent stroke (prior ischemic stroke within three months).
from Journal of the Neurological Sciences https://ift.tt/37DYEmo
from Journal of the Neurological Sciences https://ift.tt/37DYEmo
Comments
Post a Comment